Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cannabix Technologies ( (TSE:BLO) ) has issued an announcement.
Cannabix Technologies Inc. has received a notice of allowance from the Canadian Intellectual Property Office for its patent application on a contactless breath analysis device and method. This technology, which can be integrated into various environments such as vehicles and workplaces, enhances Cannabix’s leadership in breath sampling and detection, offering applications in law enforcement, workplace safety, and public health monitoring.
Spark’s Take on TSE:BLO Stock
According to Spark, TipRanks’ AI Analyst, TSE:BLO is a Underperform.
Cannabix Technologies has a low overall stock score due to severe financial challenges, characterized by zero revenue and ongoing losses. While technical indicators and recent corporate developments provide some optimism, the company’s speculative valuation and financial instability remain significant concerns.
To see Spark’s full report on TSE:BLO stock, click here.
More about Cannabix Technologies
Cannabix Technologies Inc. is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement, and other settings. The company focuses on breath testing for delta-9 THC, the primary psychoactive ingredient in cannabis, and has developed the BreathLogix autonomous alcohol screening device.
Average Trading Volume: 26,429
Technical Sentiment Signal: Buy
Current Market Cap: C$69.09M
For a thorough assessment of BLO stock, go to TipRanks’ Stock Analysis page.